drugset / Trial / NCT01495858

Evaluate Analgesic / Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain

NCT01495858

Phase 3 Completed 267 enrolled Bayer
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of the study is to evaluate the efficacy and safety of a single oral dose of naproxen sodium 440 mg in combination with DPH (diphenhydramine) 25 mg in subjects with postsurgical dental pain and phase advanced sleep.

Timeline

Start
2011-12
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphenhydramine Unknown 25 mg Oral
Subject Diphenhydramine Unknown 50 mg Oral
Subject Naproxen Small molecule 440 mg Oral

Indications

No indication recorded.